# Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma

> **NCT07245368** · PHASE1,PHASE2 · RECRUITING · sponsor: **Prana Therapies Inc** · enrollment: 96 (estimated)

## Conditions studied

- Mild to Moderate Asthma

## Interventions

- **DRUG:** PRA-216
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07245368
- **Lead sponsor:** Prana Therapies Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-04
- **Primary completion:** 2026-10-01
- **Final completion:** 2027-01-31
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07245368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07245368, "Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07245368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*